ABSTRACT
Background: In 2013 the Chilean regulatory sanitary agency issued a warning concerning dose adjustment and use restriction to avoid severe adverse effects of metoclopramide such tardive dyskinesia. Aim: To study dyskinesia type adverse effects in a population using metoclopramide. Material and Methods: A cross sectional observational study was conducted among patients pertaining to palliative care and diabetes mellitus programs and consuming 10 mg/day or more of metoclopramide. Patients were interrogated looking for extrapiramidal signs and symptoms using a questionnaire validated by two neurologists. Results: In 40% of diabetic patients with gastroparesia and 35% of palliative care patients, extrapyramidal adverse reactions to metoclopramide were suspected. Palliative Care patients suffered the largest number of adverse events. The period of use and individual doses of the drug were largely above Chilean regulatory agency recommendations in all cases. Conclusions: A significant number of patients using metoclopramide could experience extrapyramidal adverse reactions.
Subject(s)
Humans , Male , Female , Pain/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Dopamine D2 Receptor Antagonists/adverse effects , Metoclopramide/adverse effects , Palliative Care , Chile , Cross-Sectional Studies , Surveys and Questionnaires , Pharmacovigilance , Dopamine D2 Receptor Antagonists/administration & dosage , Metoclopramide/administration & dosageABSTRACT
Se analizan en forma retrospectiva las historias clinicas y los registros de anestesia para realizar 40 trasplantes renales entre Abril de 1985 y Abril de 1989. Los pacientes estaban sometidos a hemodialisis periodica, representativos de una fase final de falla renal cronica con un alto indice de alteraciones cardiovasculares y bioquimico, seleccionado para trasplante renal intrafamiliar y de cadaver, segun protocolo por su compabilidad inmunologica, edad, estado clinico, consentimiento familiar y condiciones anatomo-quirurgicos de donantes y receptores. La mayoria recibio anestesia general con barbiturico intravenoso, relajante muscular, agentes inhalatorios con suplemento narcotico, otros en menor numero, anestesia raquidea o peridural y en pequena proporcion una combinacion de las tecnicas. No ocurrieron decesos intraoperatorios, una muerte postoperatoria en recuperar se atribuyo a diuresis excesiva y profunda hipokalemia; no se presentaron complicaciones cardiovasculares y respiratorias inmediatas. Un pequeno numero de pacientes requirio nuevos procesos anestesicos inmediatos y taridos por sospecha de rechazo agudo compresion o torsion venosa y arterial, obstruccion ureteral, coagulos sanguineos vesicales o fistulas del trayecto uretero-vesical. A dos enfermos se les retiro tardiamente el injerto trasplantado